Clinical outcomes of newborn screening for cystic fibrosis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 80, Issue 1, 1999, Pages

  Waters, Donna L ^a   Wilcken, Bridget ^b   Irwig, Les ^b   Van Asperen, Peter ^b   Mellis, Craig ^b   Simpson, Judy M ^b   Brown, John ^b   Gaskin, Kevin J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b NONE

Author keywords

Clinical outcomes; Cystic fibrosis; Early diagnosis; Neonatal Screening

Indexed keywords

ARTICLE; CHILD DEVELOPMENT; CHILD GROWTH; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033060620     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.80.1.F1     Document Type: Article

References (31)

1. 1 Wilcken B. Newborn screening for cystic fibrosis: its evolution and a review of the current situation. Screening 1993;2:43-62.
2. 2 Farrell PM, Mischler EH. Newborn screening for cystic fibrosis: The cystic fibrosisneonatal screening study group. Adv Pediatr 1992;39:35-70.
3. 3 Heeley AF, Bangert SK. The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood. Ann Clin Biochem 1992;29:361-76.
4. 4 Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. Application of DNA analysis in a population screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet 1993;52:616-26.
5. 5 Wilcken B, Wiley V, Sherry G, Bayliss U. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediatr 1995;127:965-70.
6. 6 Waters DL, Dorney SFA, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990;322:303-8.
7. 7 Ad Hoc Committee Task Force on Neonatal Screening, Cystic Fibrosis Foundation. Neonatal screening for cystic fibrosis: position paper. Pediatrics 1983;72:741-5.
8. 8 Al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet 1990;38:460-5.
9. 9 Boland C, Thompson NL. Effects of newborn screening of cystic fibrosis on reported maternal behaviour. Arch Dis Child 1990;65:1240-4.
10. 10 Helton JL, Harmon RJ, Robinson N, Accurso FJ. Parental attitudes toward newborn screening for cystic fibrosis. Pediatr Pulmonol 1991;Suppl 7:23-8.
11. 11 Perobelli S, Faraguna D, Giglio L, et al. False positive screening for cystic fibrosis: reactions in parents and attitudes of professionals. In: Travert G, ed. Mucoviscidose: Dépistage Néonatal et Prise en Charge Précoce. Caen: CHRU de Caen, 1988:203-14.
12. 12 Marcus MS, Sondel SA, Farrell PM, et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991;54:578-85.
13. 13 Reardon MC, Hammond KB, Accurso FJ, et al. Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test. J Pediatr 1984;105:271-4.
14. 14 Holliday KE, Allen JR, Waters DL, Gruca MA, Thompson SM, Gaskin KJ. Growth of human milk-fed and formula-fed infants with cystic fibrosis. J Pediatr 1991;118:77-9.
15. 15 Wilcken B, Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet 1985;2:1319-21.
16. 16 Mastella G, Barlocco EG, Antonacci B, et al. Is neonatal screening for cystic fibrosis advantageous? The answer of a wide 15 years follow-up study. In: Travert G, ed. Mucoviscidose: Dépistage Néonatal et Prise en Charge Précoce. Caen: CHRU de Caen, 1988:127-43.
17. 17 Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening in a cystic fibrosis centre. Thorax 1995;50:712-18.
18. 18 Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991;66:29-33.
19. 19 Mischler E, Farrell P, Bruns T, et al. Progress report: Neonatal screening for cystic fibrosis in Wisconsin. Wis Med J 1989;88:14-18.
20. 20 Farrell PM, Aronson RA, Hoffman G, Laessig RH. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing. Wis Med J 1994;93:415-21.
21. 21 Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997;337:963-9.
22. 22 Corey M, Levison H, Crozier D. Five-to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis 1976;114:1085-92.
23. 23 Dibley MJ, Goldsby JB, Staehling NW, Trowbridge FL. Development of normalised curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-48.
24. 24 Zeger SL, Liang K-Y, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60.
25. 25 WHO: Annex 3: reference data for the weight and height of children. In: Measuring change in nutritional status: guidelines for assessing the nutritional impact of supplementary feeding programs for vulnerable groups. Geneva: World Health Organisation, 1983:61-101.
26. 26 Kristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992;50:1178-84.
27. 27 Ranieri E, Lewis BD, Gerace RL, et al. Neonatal screening for cystic fibrosis using immunoreactive trypsin and direct gene analysis: four years' experience. BMJ 1994;308:1469-72.
28. 28 Spence WC, Paulus-Thomas J, Orenstein DM, Naylor EW. Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity. Biochem Med Metab Biol 1991;46:105-9.
29. 29 Strong TV, Smit LS, Turpin SV, et al. Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels. N Engl J Med 1991;325:1630-34.
30. 30 The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-13.
31. 31 Weaver LT, Green MR, Nicholson K, et al. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child 1994;70:84-9.